One study reported that the assessment of pretreatment specific IgE levels is not helpful in predicting the outcome of anti-IgE treatment (47) and a second even suggested that Omalizumab treatment is also effective in non-atopic asthma (48). The gene discussed is IGHE; the disease is atopic asthma.